Yuichi Teraki
Saitama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Effects of interleukin-17 inhibitors on hepatic fibrosis index in patients with psoriasis and metabolic dysfunction-associated fatty liver disease: Directed acyclic graphs.
Journal: Clinical and molecular hepatology
Published: February 11, 2022
Treatment of bullous pemphigoid with dupilumab: Dupilumab exerts its effect by primarily suppressing T-helper 2 cytokines.
Journal: The Journal of dermatology
Published: February 08, 2022
Interleukin (IL)-13/IL-22/IL-31 skewing within the skin-homing T-cell population in papuloerythroderma.
Journal: The Journal of dermatology
Published: January 29, 2021
Treatment of recalcitrant subcorneal pustular dermatosis with guselkumab.
Journal: International journal of dermatology
Published: August 24, 2020
Combination therapy with biologic and colchicine for generalized pustular psoriasis.
Journal: International journal of dermatology
Published: March 30, 2020
Association of Propionibacterium acnes with the efficacy of minocycline therapy for cutaneous sarcoidosis.
Journal: International journal of dermatology
Published: February 17, 2020
Combination therapy of apremilast and biologics in patients with psoriasis showing biologic fatigue.
Combination therapy of apremilast and biologics in patients with psoriasis showing biologic fatigue.
Journal: The Journal of dermatology
Published: October 08, 2019
Confusion in determination of two types of cutaneous adverse reactions to drugs, maculopapular eruption and erythema multiforme, among the experts: A proposal of standardized terminology.
Journal: The Journal of dermatology
Published: September 30, 2019
Use of Dupilumab in the Treatment of Papuloerythroderma of Ofuji.
Journal: JAMA dermatology
Published: June 20, 2019
Depletion of regulatory FoxP3+ T cells in the pathogenesis of Stevens-Johnson syndrome induced by mogamulizumab.
Journal: International journal of dermatology
Published: June 10, 2019
Effects of tumor necrosis factor-α, interleukin-23 and interleukin-17A inhibitors on bodyweight and body mass index in patients with psoriasis.
Journal: The Journal of dermatology
Published: February 18, 2018
Last Updated: 09/26/2026